Michael Har-Noy - PowerPoint PPT Presentation

} ?>
View by Category
About This Presentation
Title:

Michael Har-Noy

Description:

Preliminary data show that AlloStimTM and CRCL-AlloVaxTM, two proprietary compounds developed by Dr. Michael Har-Noy, have activity against a wide variety of malignancies. Dr. Michael Har-Noy, founder and CEO of Immunovative Therapies Ltd., a biotechnology company in Israel, says that he is planning phase I/II trials of AlloStimTM in hepatocellular carcinoma and in head and neck malignancies. Dr. Michael Har-Noy is also designing phase II/III marketing trials for his drugs in patients with HER2+ breast cancer and KRAS gene positive colon cancer. Please visit www.immunocare.net for more information. – PowerPoint PPT presentation

Number of Views:277
Slides: 6
Provided by: pzmediainc
Category: Other

less

Write a Comment
User Comments (0)
About PowerShow.com